|
|
|
|
Baxter s Products & Services Directory page 14
author: Center for One Baxter
subject: For questions about our Products and Services
duplicates:
http://www.baxter.com/customers/products_svcs/2003_products_and_services_directory.pdf
|
|
|
Baxter s Products & Services Directory page 10
author: Center for One Baxter
subject: For questions about our Products and Services
duplicates:
http://www.baxter.com/customers/products_svcs/2003_products_and_services_directory.pdf
|
|
|
Baxter s Products & Services Directory
Tablets MESNEX* (MESNA) Product Information: Bristol Myers- Squibb Medical Services 800- 426- 7644 ALFENTANIL HYDROCHLORIDE INJECTION ATIVAN (LORAZEPAM) INJECTION AMIODARONE HYDROCHLORIDE INJECTION ATRACURIUM BESYLATE INJECTION ATROPINE SULFATE INJECTION, USP BUMETANIDE INJECTION BUTORPHANOL TARTRATE INJECTION, USP CISplatin INJECTION DILTIAZEM HCI INJECTION DOBUTAMINE INJECTION, USP...
author: Center for One Baxter
subject: For questions about our Products and Services
|
|
|
Enalaprilat - LKT-E5200
- - For Pricing Information click here and submit your country
LKT-E5200 Enalaprilat [LKT] - Main Category: Angiotensin-Converting Enzyme/Related Products Related Categories: - General: Product-ID LKT-E5200 Product Name Enalaprilat Product Numbers / Sizes: LKT-E5200-M010 10 mg - - LKT-E5200-M050 50 mg - - LKT-E5200-M100 100 mg - - Original Manufacturer: LKT Laboratories, Inc
|
|
|
Cedra Corp. Methods List April 2004.xls
CEDRA's List of GLP Validated, Pharmaceutical Bioanalytical Methods Drug Species AntiCoagulant Matrix Extraction Volume Range Abacavir* Human Plasma 0.05 mL 25 – 5000 ng/ mL Acetaminophen* Human Heparin Plasma 0.2 mL 0.25 – 25 µg/ mL Acetaminophen* Human Heparin Plasma 0.25 mL 0.15 – 15 µg/ mL Acetaminophen* 0.15 – 15 µg/ mL Propoxyphene* 1 –...
author: Information Systems
|
|
|
Cedra Corp. Methods List April 2004.xls page 3
author: Information Systems
|
|
|
Angiotensin-Converting Enzyme/Related Products
- - - Family view Angiotensin-Converting Enzyme/Related Products Items 1-8 of 8 Page 1 of 1 - Prod
Prod
Name Brand - ALX-270-212 Captopril ALEXIS LKT-C0261 Captopril LKT LKT-E5201 Enalapril Maleate LKT LKT-E5200 Enalaprilat LKT LKT-L3374 Lisinopril LKT ALX-270-213 S-Nitrosocaptopril ALEXIS LKT-Q8134 Quinapril hydrochloride LKT LKT-T1644 Telmisartan LKT Items 1-8 of 8 Page 1 of...
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
400, ERYTHROMYCIN ETHYLSUCCINATE E.E.S., ERYTHROMYCIN ETHYLSUCCINATE EC-NAPROSYN, NAPROXEN ECONAZOLE NITRATE, ECONAZOLE NITRATE ECONOCHLOR, CHLORAMPHENICOL ECONOPRED PLUS, PREDNISOLONE ACETATE ECONOPRED, PREDNISOLONE ACETATE EDECRIN, ETHACRYNATE SODIUM EDECRIN, ETHACRYNIC ACID EDETATE DISODIUM, EDETATE DISODIUM EDEX, ALPROSTADIL EDROPHONIUM CHLORIDE PRESERVATIVE FREE, EDROPHONIUM...
|
|
|
http://www.fda.gov/cder/dmf/text/4Q2003ACTIVETYPE2TEXT.txt
AMOXICILLIN TRIHYDRATE 13779 01-Sep-98 BRISTOL-MYERS AMPICILLIN 13780 01-Sep-98 ACS DOBFAR SPA CEFACLOR 13781 01-Sep-98 TAIWAN BIOTECH CEPHALEXIN 13782 01-Sep-98 GIST BROCADES PENICILLIN G POTASSIUM 13783 01-Sep-98 "ZHEJIAN HISUN PHARMACEUTICAL CO., LTD." "MITOMYCIN AS MANUFACTURED IN JIAOJIANG, ZHEJIANG PROVINE, CHINA" 13784 01-Sep-98 SICOR SPA BLEOMYCIN SULFATE 13785 01-Sep-98...
|
|
|
Cedra Corp. Methods List January 2004.xls page 3
author: Information Systems
|
|
|
Cedra Corp. Methods List January 2004.xls
CEDRA's List of GLP Validated, Pharmaceutical Bioanalytical Methods Drug Species AntiCoagulant Matrix Method Range Abacavir* Human Plasma LC- MS- MS 25 – 5000 ng/ mL Acetaminophen* Human Heparin Plasma HPLC 0.25 – 25 µg/ mL Acetaminophen* Human Heparin Plasma LC- MS- MS 0.15 – 15 µg/ mL Acetaminophen* 0.15 – 15 µg/ mL Propoxyphene* 1 – 150 ng/...
author: Information Systems
|
|
|
75-456 & 75-458 Enalaprilat
Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Enalaprilat Injection Company:--Abbott Laboratories Application No.:--75-456 & 75-458 Approval Date:-8/22/2000 - Approval Letter(s) - Printed Labeling - Chemistry Review(s) - Microbiology Review(s) - Bioequivalence Review(s) - Administrative Document(s) - Correspondence - - Back...
author: Paul Stauffer
|
|
|
Methods
- Cefuroxime , Doxylamine , Norfloxacin , Ofloxacin , Propofol -- - ANALYTE ---- LLOQ METHOD MATRIX -- A cebutolol 10.0 - ng/mL HPLC-UV Plasma -- -- diacetolol 10.0 - ng/mL -- - -- Acetaminophen 0.500 - mcg/mL HPLC-UV Plasma - Acyclovir 10.0 - ng/mL HPLC-Fluorescence Plasma - Albuterol 0.500 - ng/mL HPLC-Fluorescence Serum - Alprazolam 0.500 - ng/mL GC-ECD Serum - Amiodarone 5.00 -...
|
|
|
Reference Listed Drug Labeling Approved in November 2001
Nov 1 COREG letter ---- carvedilol tablets 20-297 S-007 INDERIDE LA letter label propranolol HCl/HCTZ extended-release capsules 19-059 S-016 INDERIDE letter label propranolol HCl/HCTZ tablets 18-031 S-030 Nov 5 TAMIFLU letter label oseltamivir phosphate suspension oseltamivir phosphate capsules 21-246 21-087 S-004 S-009 Nov 7 REGLAN letter label metoclopramide HCl solution...
author: USERNAME
|
|
|
Reference Listed Drug Labeling Approved in November 2002
Food and Drug Administration • Center for Drug Evaluation and Research Office of Generic Drugs Search Reference Listed Drug Labeling and Efficacy Supplements Approved in November 2002 Click on appropriate hyperlink below to view available source document in PDF format Approval Date Product Name Source Documents Active Ingredient(s)/Dosage Form Document ID No
Nov 1 ALLEGRA-D...
author: USERNAME
|
|
|
Preventable Adverse Drug Reactions: A focus on drug interactions
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Preventable Adverse Drug Reactions:-- A Focus on Drug Interactions This learning module was developed based on a needs survey sent to all third year medicine clerkship directors and all medicine residency program directors in the United States.- This module was developed by the Center...
author: OPDRA
|
|
|
OGD, Tentative Approvals May 2000
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Office of Generic Drugs ANDAs Tentative Approvals May 2000 - 1
75-396 MIDAZOLAM HYDROCHLORIDE FAULDING PHARMACEUTICAL 5/5/00 INJECTION 1 MG (BASE)/ML 5 CO
MG (BASE)/ML 2
75-672 BISOPROLOL FUMARATE AND PUREPAC PHARMACEUTICAL 5/11/00 HYDROCHLOROTHIAZIDE CO
TABLETS 2.5 MG/6.25...
author: USERNAME
|
|
|
ANDAs Approvals - August 2000
Food and Drug Administration • Center for Drug Evaluation and Research Drug Information Search Office Of Generic Drugs ANDAs Approvals August 2000 1
MG 20 MG 4
75-456 ENALAPRILAT INJECTION 1.25 ABBOTT LABORATORIES 8/22/00 MG/ML (SYRINGE) 7
75-458 ENALAPRILAT INJECTION 1.25 ABBOTT LABORATORIES 8/22/00 MG/ML (VIALS) 8
75-459 ENALAPRIL MALEATE LEK...
author: USERNAME
|
|
|
Hypertensive Emergencies
Kidneys Hypertensive Retinopathy: • Grade I: minimal narrowing of arterioles • Grade II: “copper” and “silver” wiring and AV nicking Grade III: cotton wool spots, hard exudates and hemmorhages and extensive microvascular change Grade IV: above + disk edema – – (note: AS protects from the arteriolar spasm that is the underlying mechanism for Gr...
author: Dave Dyck
|
|
|
http://www.crha-health.ab.ca/em/reseduc/residentround/chf&cm.ppt
POWERPOINT Shot Through the Heart & You’re to Blame,You Give Love a Bad Name: CHF & Cardiomyopathy Resident Rounds Nov 28/02 A.F
Is very sensitive and will be released even with exercise
Yeah, you know me
• If patients have COPD, are at risk for PE and have a history of CHF then BNP can help separate cardiac from other causes of dyspnea – – Maisel AS,...
|
|
|
MFCL -- PRODUCTS -- VASOTEC-IV®
var section = "products"; Disclaimer Pr VASOTEC ® -I.V
(enalaprilat injection) --October 7, 1991 Angiotensin Converting Enzyme Inhibitor Date of Revision: December 18, 2002 (809-a,1,03) File name: VASOTEC_809-a-1-03-E.pdf File size: 114K DISCLAIMER The contents of this site, including but not limited to Merck Frosst product information and product monographs, are for...
|
|
|
http://www.fda.gov/cder/ogd/rld/RLD_LABELING_APPROVED_FEB_1999.HTML
Firm Date BRETHINE Terbutaline Sulfate Tablet 17-849 032 Novartis Pharms 2-Feb-1999 CHLOROMYCETIN Chloramphenicol Opth Ointment 50-156 038 Parkedale 3-Feb-1999 PRILOSEC Omeprazole Delayed-Release Capsule 19-810 057 Astra Merck 3-Feb-1999 TRANSDERM-NITRO Nitroglycerin Transdermal System 20-144 018 Novartis Pharms 3-Feb-1999 PRIMAXIN Cilastatin Sodium/Imipenem Injection 50-587 50-630...
|
|
|
FDA Drug Approvals List November 2001
REDDY'S LABORATORIES LIMITED Active Ingredient(s): IBUPROFEN OTC/RX Status: RX Original Abbreviated Application # 075347 Approval Date: 16-NOV-01 Trade Name:OMEPRAZOLE Dosage Form: CAPSULE Applicant: ANDRX PHARMACEUTICALS, INC Active Ingredient(s): OMEPRAZOLE OTC/RX Status: RX Original Abbreviated Application # 075682 Approval Date: 14-NOV-01 Trade Name:IBU Dosage Form: TABLET...
|
|
|
LIST OF APPROVED DRUGS FOR WHICH ADDITIONAL PEDIATRIC INFORMATION
DOCKET NO
Anti-Infective Drug Products Ampicillin/sulbactam Skin/skin structure infections and intraabdominal infections
Anesthetic, Critical Care And Addiction Drug Products Bupropion Treatment of depression
Metabolic And Endocrine Drug Products Dexmedetomidine Sedation of initially intubated and mechanically ventilated patients in an ICU setting
Anti-Viral Drug Products...
|
|
|
Prescription and OTC Drug Product List 5/2002
2 -D- + ROBINS AH 325MG;15MG N84444 001 MAY DISC -A- @ 325MG;15MG N84444 001 MAY DISC SOLUTION; ORAL ACETAMINOPHEN AND CODEINE PHOSPHATE -D- AA ALPHARMA 120MG/5ML;12MG/5ML N85861 001 MAY CRLD -A- AA + 120MG/5ML;12MG/5ML N85861 001 MAY CRLD TYLENOL W/ CODEINE -D- AA + JOHNSON RW 120MG/5ML;12MG/5ML N85057 001 MAY DISC -A- @ 120MG/5ML;12MG/5ML N85057 001 MAY DISC TABLET; ORAL...
|
